Development and Utility of an Imaging System for Internal Dosimetry of Astatine-211 in Mice
In targeted radionuclide therapy, determining the absorbed dose of the ligand distributed to the whole body is vital due to its direct influence on therapeutic and adverse effects. However, many targeted alpha therapy drugs present challenges for in vivo quantitative imaging. To address this issue,...
Main Authors: | Atsushi Yagishita, Miho Katsuragawa, Shin’ichiro Takeda, Yoshifumi Shirakami, Kazuhiro Ooe, Atsushi Toyoshima, Tadayuki Takahashi, Tadashi Watabe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/11/1/25 |
Similar Items
-
Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
by: Hiroki Kato, et al.
Published: (2021-07-01) -
Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine
by: Ayaka Aso, et al.
Published: (2023-05-01) -
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection
by: Xuhao Huang, et al.
Published: (2022-12-01) -
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
by: Sadahiro Naka, et al.
Published: (2024-04-01) -
Surface Adsorption of the Alpha-Emitter Astatine-211 to Gold Nanoparticles Is Stable In Vivo and Potentially Useful in Radionuclide Therapy
by: Emanuel Sporer, et al.
Published: (2021-10-01)